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Osteoarticular iatrogenic infections may be serious and justify suitable and optimised 
preventive measures depending on each risk, as much in terms of mortality as of morbidity. 
Its appreciation has been the subject of more and more studies which allow the importance 
of the problem to be better evaluated. The level of iatrogenic infections after arthroscopy is 
evaluated at 1 to 5‰ on a recent series of knee operations, but they may be much higher for 
the elbow [1,2]. In practice, this examination is no longer used for diagnosis as it was 10 
years ago, the progress in imagery means this invasive act is no longer necessary. In a recent 
meta-analysis, prosthetic surgery led to a level of deep iatrogenic infection of about 9‰ for 
the hip, but with a confidence interval of 95%, included between 4 and 22‰ [3]. 
Significantly, the existence of a perioperative wound with secondary infection is associated 
with iatrogenic infection. In 20% of the cases, these are Methicillin resistant staphylococcus. 
The level of infection for shoulder replacements is of the same magnitude of 10‰, but is 
around 20‰ for knee replacements [4]. Prior cortisone local injections do not appear to 
increase the risk of later sepsis [5]. However, the increase in asepsis, with the 
implementation of laminar airflow in operating theatres, does not appear to increase the 
level of security for the considerable additional costs [6]. Although, it is clear that asepsis 
measures reduce the risk of iatrogenic infections, it is more difficult to determine the 
optimal threshold of preventive measures necessary without falling for an excess of costly 
and not very profitable measures. 
Where are we with articular and periarticular local injections? At the present time, we only 
have retrospective inquiries available, with very low levels of iatrogenic infections, between 
0.002 and 0.07‰ (table 1)[7-13]. A prospective study will be very difficult to carry out with 
the necessary number of patients, in the hundreds of thousands with no losses, to follow-up, 
taking account of the rarity of the event. Two studies have recently been published after on 
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the ground enquiries looking for the totality of real septic arthritis cases found in a given 
population [7,11]. However, the figures that have been discovered are particularly divergent: 
0.026‰ (close to previous enquiries) for one and 0.37‰ for the other, i.e. a difference by a 
factor of 10. How do we explain this difference? If the number of sepsis has been the subject 
in the 2 exhaustive research studies, the methodology was quite different to evaluate the 
number of interventional local injections acts. In the Icelandic study, it is the number of acts 
charged for and reimbursed which was used. In the French study, a real evaluation over a 2 
weeks period was carried out with 98% of rheumatologists in the region who perform 3/4 of 
the local injections. In France, when a local injection is performed, the associated 
consultation may be quoted in the database and be reimbursed, without the act performed 
appearing. The database largely underestimates the number of acts performed. The French 
population is also much more important (1,290,533 versus 287,559), with the number of 
acts retained more than 10 times greater (75,698 versus 6,891). Furthermore, the local 
injection technique and asepsis used are unknown to the Icelandic Doctors, for a previous 
old period 1990-2002. In the French study, clean hands, with or without sterile gloves, 
single-use equipment and use of iodine or Chlorhexidine type antiseptics were the order of 
the day. The difference between the 2 figures is important: 0.37‰ and it is close to the 1-
5‰ of arthroscopies, which may justify operating type asepsis measures, whilst with only 
0.026‰ this very low risk would not appear to justify additional preventive measures to 
what is actually practised and recommended in France by the HAS [14]. For our part, and in 
agreement with the results, the recommendations and practices carried out in France, we 
retain as level for iatrogenic infections after rheumatology interventions the figure of 
0.026‰. 
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The balance benefits – risks from local injections should be evaluated to estimate if the 
negative incidence of local injection risk is largely outweighed by the beneficial positive 
effects. The centres who practice and evaluate the benefits of osteoarticular local injections 
techniques find satisfaction levels reaching 90% [15]. In the evaluation carried out by Zhou 
covering 771 interventional acts, the EVA fell from 6.7 to 2.4 after the therapeutic 
interventional act, with a NNT for an improvement of more than 50% to 1.4 [15]. Iatrogenic 
infection remains as the most serious complication, with risk of rapid articular destruction 
and definitive secondary functional impotence. If mortality from osteoarticular infections 
remains high, it is difficult to evaluate the importance of morbidity and mortality of these 
osteoarticular infections after local injections, based on the literature. Only one death has 
been found, related to an important diagnostic delay [16]. It remains that a patient informed 
of the risk should allow for rapid care and few sequelae. We can only insist on the 
indispensable character of patient information, better guarantee of early care for an 
eventual complication to avoid sequelae. The balance, benefit-risk however remains largely 
positive (Figure 1). 
SIRIS (Section Imagerie et Rhumatologie Interventionnelle de la Société Française de 
Rhumatologie) (Imaging and Interventional Rheumatology Group of the French 
Rheumatology Society) proposes suitable preventive measures for each act depending on 
each particular patient risk and in each environment (Table 2). In fact, the septic risk 
depends on the type of act: the number of acts, the aggressive character and size of the 
cutaneous puncture, duration of the act. It is important to define the notion of sterile zone – 
clean zone interface. So, the surgeons hand must be sterile, the same as all the parts of his 
body that contributes to movement near the operating site (sterile scrub). For acts with a 
simple cutaneous puncture, after asepsis of the skin with major antiseptics such as iodine or 
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Chlorhexidine antiseptics, the choice may be made between the sterile – clean interface at 
the level of either the hand (sterile gloves and clean clothes), or either the needle or the 
syringe. On one hand, certain product syringes are not guaranteed sterile, and the problem 
of having a hand in a non-sterile glove which holds the syringe makes us consider that we 
should take account of the syringe-needle interface for simple acts. However, touching the 
needle or its connector should be avoided by introducing the "double no touch" notion, 
don't touch either the skin or the needle. Patients at risk also justify more additional 
measures: ageing, malnutrition, obesity, diabetic, prior surgery, haematopathy, cirrhosis, 
distant infections, carrying AIDS, iatrogenic (chemotherapy, biotherapy) and family 
immunodeficiency. Finally, the ambient surroundings need to be taken into account, with 
infection risk and germ virulence being different, depending on the place (medical office, 
radiology, clinic, hospital). 
We have established these recommendations by taking into account the literature data, 
from an open enquiry with rheumatologists during a congress of the French Society of 
Rheumatology (after a communication in December 2011) , and the advice from SIRIS 
experts (co-authors). We have seen that the techniques were very different from one person 
to another, with a clear increase in asepsis measures with the youngest. We propose 
recommendations albeit tempered, with a request for optimisation of each procedure, but 
without falling into the excess of precaution of the operation type, both costly and 
ineffective. 
We have distinguished the usual acts, whether they are superficial or deep, periarticular 
(shoulder, elbow, wrist, hip, knee, ankle, foot, plantar fasciitis, trigger finger, finger 
retinaculum section), tunnels (carpel, tarsal, Morton, pelvis, shoulder), or articular (shoulder 
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complex, elbow, wrist, finger, hip, knee, ankle, tarsal, foot, sternoclavicular, 
temporomandibular, zygapophyseal), more complex acts such as puncture aspiration of 
calcifications, cementoplasty, aponeurotomy, wrist retinaculum section, bone, synovial or 
muscular biopsies. Certain people are tempted to propose stricter prevention methods for 
deeper after local injections, such as the hip or sacroiliac. There is no data which allows this 
direction to be followed. Surveillance should simply be more precise concerning the absence 
of visible inflammatory signs for these deep articulations. Guidance (fluoroscopic, ultrasound 
or scan) may be an additional risk. It may be the environment of the x-ray table where all the 
potentially infected patients pass. Additional precautionary measures should be taken (level 
2), and the room disinfected after each passage suspected of being an infection risk. Ideally, 
a room dedicated to osteoarticulations would be preferable. CT-scan requires several 
comings and goings between the guide and the image controls, which justifies additional 
precautions and also changing to level 2. Ultrasound guidance presents a risk of contact with 
the probe, the needle should at all times be at least 1 cm away. Technical aids may be of use: 
an articulated arm to keep the probe close by without the need to rest it on another 
support, protecting the probe, the context of which will decide if this should be sterile or 
not, and a foot pedal to take the reference images. For all these guided acts, an assistant 
may be needed when the act is complex. However, for the more usual acts, there is no data 
justifying stricter precautionary measures for an ultrasound guided act compared to an act 
relying on anatomical guidance. The ASA score defines in anaesthesia the overall health 
state and the potential fragility of the patient. The HAS has established recommendations as 
to the optimal environment necessary to perform interventional acts [17]. This environment, 
with an eventual assistance for performing more complex acts, and above all surveillance 
after the interventional act will be adapted case by case for the ASA 3 & 4. The anaesthetic 
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will remain local, with possible nerve or distal block. But an ASA 4 patients, locoregional 
proximal and plexus block anaesthetic techniques, and associated sedations justify the 
presence of a nearby anaesthetist. The characteristics of the required first aid kit are also 
specified. Note that the necessity to have an oxygen supply for level 1 (HAS 
recommendation) is far from unanimous for interventional rheumatologists. The quality of 
the environment or place where the act is performed is subject to a certain number of 
criteria between level 1 and 2, level 3 remaining as the operating theatre, but it is the 
cleanliness and its traceability that will be preponderant. A room or immediate surveillance 
area is required for level 2. Disinfection is required after the passage of an infected patient. 
Additional risk elements may envisage changing a patient from level 1 to level 2, on a case by 
case basis and depending on the practitioner’s appreciation: infectious risk, general situation 
(ASA 3, poorly balanced), for example obvious allergic risk, anticoagulants or antiplatelets, 
morbid obesity, malnutrition, dementia. The HAS propose to define intermediate levels 2a 
and 2b. The intermediate level 2a is a level 1 with reinforced asepsis (sterile gloves, sterile 
probe protection), with optional assistant, without however justifying the presence of an 
anaesthetist close by. This level 2a could be used for risk patients (ASA 3 or infectious risk) 
and for the use of a mix of nitrous oxide 50% and oxygen 50% (gas and air). Level 2b is the 
equivalent of level 2. It could be reinforced only if estimated to be necessary (antiseptic 
shower, sterile gloves and scrub, cap), in an environment close to those found in the 
operating theatre (level 3). Biopsy acts justify stricter asepsis measures as they include as 
secondary benefit a diagnosis dimension and not therapeutic. 
In total, even if these recommendations should be indicators, that one can adapt case by 
case, nothing justifies an inflation of asepsis protection measures within the scope of 
'principle of precaution' which may be just as useless as expensive if we consider the more 
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than 2 million interventional rheumatology acts performed each year in France, with less 
than 100 septic complications of which less than 10 are subject to claims for damages. 
There is no conflict of interest to be declared by the authors. 
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Table 1: Level of iatrogenic osteoarticular infections in interventional rheumatology 
for 1 000 acts. 
In France 
Séror (Rheumatology 1999) 0.015 
Lebrun (Rheumatologist Letter 1999) 0.015 
Maugars (Rev Rhum 2013) 0.026 
In Great Britain 
Weston (Ann Rheum Dis 1999) 0.002 
In the USA 
Hollander (State Med J 1970) 0.067 
Gray (Clin Orthop 1993) 0.020 
In Iceland 
Geirsson (ARD 2008) 0.37% 
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Table 2: SIRIS recommendations for patient, practitioner and material asepsis and adapted 
environment for interventional rheumatology 
Level 1 
Usual injections and acts 
Level 2 
More complex injections and acts 
T PE OF INJECTION -periarticular (shoulder, elbow, wrist, hip, knee, ankle, 
foot, plantar fascia, trigger finger, finger retinaculum 
section
a
) 
- tunnels (carpal, tarsal, Morton, pelvic, shoulder) 
- articular (shoulder complex, elbow, wrist, finger, hip, 
sacroiliac, knee, ankle, tarsal, foot, sternoclavicular, 
ATM, interapophyseal) 
- epidural (interlaminar or caudal) or foraminal 
- Puncture aspiration of calcification, cementoplasty, 
kyphoplasty, aponeurotomy, wrist retinaculum section 
- bone, synovial or muscular biopsies 
PAT IENT ASEPSIS local disinfection of the skin using iodine or 
Chlorhexidine antiseptic, wait 2' (if alcohol solution: 30") 
"no touch" skin procedure 
clean in 5 steps if poor cleanliness 
local disinfection of the skin using iodine or 
Chlorhexidine antiseptic, wait 2' (if alcohol solution: 30") 
"no touch" skin procedure 
clean in 5 steps if poor cleanliness 
PRAC TITIONER'S 
ASEPSIS 
clean hands (hydroalcoholic gel) after each patient, non-
sterile gloves 
paper mask, glasses if risk of projection 
clean gown or clothes 
clean hands (hydroalcoholic gel) after each patient, 
sterile gloves 
paper mask, glasses if risk of projection 
clean gown or scrub 
 MATERIAL ASEPSIS single-use equipment 
clean or sterile compresses and sterile syringe 
"no-touch" sterile needle 
single-use equipment 
clean or sterile compresses and sterile syringe 
"no-touch" sterile needle 
 GUIDED INJECTIONS
Ultrasound: probe and cable cleaned with wipe or 
antiseptic solution, non-sterile probe protection (+ non-
sterile gel), respect the distance needle - probe > 1 cm 
Fluoroscopy: protective material cleaned with antiseptic 
after each patient 
Ultrasound: probe and cable cleaned with wipe or 
antiseptic solution, sterile probe protection (+ non-
sterile gel), respect the distance needle - probe > 1 cm 
Fluoroscopy: protective material cleaned with antiseptic 
after each patient 
PATIENT RISK
High infectious risk judged important
b
: possible 
evaluation case by case to pass to level 2
a
  
General acceptable risk: ASA
c
 1-2 even 3 
Anaesthesia: local or digital block or distal block 
High infectious risk: reinforced level 2 may be 
considered
d
 
General risk: ASA
c
 1-2-3 even 4 
Anaesthesia: local or locoregional, plexus block, possible 
associated sedation, gas and air
a
 
Anaesthetist available at proximity if necessary 
 FIRST AID KIT
Blood pressure instrument, stethoscope, oxygen
e
 (mask 
or nasal canula) 
SC adrenalin, SC atropine, corticoid, antihistamine 
(+ analgesics, NSAIDs) 
Optional: anticonvulsant, bronchodilator, intravenous 
fluids 
Blood pressure instrument, stethoscope, thermometer, 
ECG apparatus, oxygen (mask or nasal cannula), 
oxymeter, intubation and aspiration cannula, 
laryngoscope, ventilation mask, ventilator (manual or 
automatic), defibrillator,  
SC adrenaline, SC atropine, corticoid, antihistamine, 
bronchodilator, ephedrine, anticonvulsant (Flumazenil 
type), +/- muscle relaxant (Dantrolene type)  
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(+ analgesics, NSAIDs) 
Intravenous perfusion material, physiological serum and 
hyperosmolar solution 
 ENVIRONMENT
Fitted out consultation room: treatment area separate 
from the office area, hygiene traceability, single-use 
equipment, asepsis of potentially unclean elements 
(reinforced for guided acts), circuit for waste disposal, 
aeration, washable examination table, swivel lamp, 
portable tablet, wash basin, closed cabinet 
Optional assistant 
Fitted out consultation room with in addition: zone for 
cleaning and disinfection, reinforced and regular 
asepsis, decontamination zone, operating table (+/- 
ventilation, sas (air-lock) entrance, electric generator) 
Simple recovery room 
Assistant 
a possibility of an intermediate level 2a (sterile gloves, sterile probe protection, optional assistant) 
b ageing, malnutrition, obesity, diabetic, prior surgery, haematopathy, cirrhosis, distant infections, carrying AIDS, iatrogenic 
(chemotherapy, biotherapy) or family immunodeficiency 
c ASA score: 1 = patient normal ; 2 = patient with moderated systemic anomaly; 3 = patient with severe systemic 
anomaly; 4 = patient with severe systemic anomaly representing a constant vital threat; 5 = patient moribund 
whose survival is unlikely without 'intervention 
d addition of cap and sterile scrub
e this HAS recommendation for level 1 is not approved by the majority of the experts 
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Figure 1: Balance benefits-risks from osteoarticular after local injections 
Potential 
seriousness 
Risks 
iatrogenic infection 
0.026‰ 
Benefits 
improvement 
up to 90% 
Weight of preventive 
measures 
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